Alendronate and hormone replacement therapy in the prevention of osteoporotic fracture: a pharmacoeconomic analysis employing a net-benefit regression method of cost-effectiveness
Repository
Alendronate and hormone replacement therapy in the prevention of osteoporotic fracture: a pharmacoeconomic analysis employing a net-benefit regression method of cost-effectiveness
| Title: | Alendronate and hormone replacement therapy in the prevention of osteoporotic fracture: a pharmacoeconomic analysis employing a net-benefit regression method of cost-effectiveness |
| Author: | Tiller, Kevin Wade |
| Abstract: | Not available |
| Department: | Pharmacy |
| Subject: |
Osteoporosis in women--Treatment--Cost effectiveness
Osteoporosis in women--Prevention--Cost effectiveness Osteoporosis in women--Treatment Osteoporosis in women--Risk factors Osteoporosis in women--Epidemiology Osteoporosis in women--Hormone therapy--Cost effectiveness Osteoporosis in women--Hormone therapy |
| URI: | http://hdl.handle.net/2152/1271 |
| Date: | 2004 |
Files in this work
This work appears in the following Collection(s)
-
UT Electronic Theses and Dissertations
ETD is a collection of UT Austin authored electronic dissertations.